MONALISA

Patients who present with gynecologic changes due to decrease in estrogen

Natural or induced pre and post menopausal women

Patients with a history of breast cancer, thrombophlebitis or other contraindications to estrogen therapy

Women who cannot or do not want to undergo risky hormone replacement

Women with inadequate response to estrogen therapy or decline of treatment results with estrogen

Women who experience soreness or pain during sexual activity

Women who do not want to undergo major surgery but want relief from their symptom

Dr. Bahnmiller has carefully evaluated all of the devices currently on the market and ultimately chose the MonaLisa Touch®.

The MonaLisa Touch® treatment is a CO2 fractional vaginal laser treatment specifically designed and FDA approved for vaginal atrophy. The other devices on the market (ex. Femilift and ThermiVa) do not have approval for vaginal laser treatment, and their probes are not FDA approved.

The MonaLisa Touch® is the only one with a clinically proven track record for safety, efficacy and patient satisfaction and the most studied in medical literature.

The MonaLisa Touch® treatment offers significant advantages over current treatment involving medications.

The MonaLisa Touch® creates longer-lasting relief (1-2 years) than current treatments with other modalities.

Pregnant or within 3 months postpartum, or nursing

Have had an abnormal pap smear

If you are under evaluation for issues related to gynecologic, urologic or gastrointeral diseases

History of reconstructive pelvic surgery with “mesh kits” or mesh in use for restoration surgery

Vaginal, cervical, or other lesions in the treatment area that have not been evaluated and diagnosed

Active vaginal or vulvar infection (herpes, candida, HPV, STDs)

Prolapse beyond hymen

History or radiation to vaginal/colo-rectal tissue

History of impaired wound healing

History of keloid formation

Known anticoagulation treatment or thromboembolic condition

Developing tumors or cancers in the area

Women who are treating post chemo or radiation therapy should wait at least 6 months after therapy has finished and will require a written authorization from their attending physician to treat with the MonaLisa Touch®.

We already have extensive experience in women’s general and sexual.

The MonaLisa Touch® is the International Gold Standard in technology for laser vaginal rejuvenation. Created specifically for vaginal treatments, and all studies in this area have been performed with this laser. This is an important consideration as science must always prove the success of a treatment before it should be used on patients.

The MonaLisa Touch® is life-changing for women everywhere. We are so thrilled to be able to offer this amazing vaginal laser treatment & procedure to help women everywhere get back to a pain-free and more enjoyable lifestyle.

This procedure is done exclusively by Dr. Bahnmiller.

The MonaLisa Touch® procedure uses a fractionated CO2 laser to stimulate the body’s own regenerative processes, creating more hydrated and healthy cells, and improving the circulation and nutrient supply to the vaginal mucosa.

This has a direct effect on the integrity and elasticity of the vaginal wall and returned the internal vaginal environment to more normal levels.In as a little as 30 days after treatment, the regeneration of new tissue in the vaginal wall builds a naturally stronger structure and the protective mucosa recovers volume, hydration and elasticity.

There is no anesthetic required as the procedure itself is relatively quick and most patients don’t have any pain before or after the procedure. Some patients may experience some slight discomfort, but this is usually more from their initial symptoms rather than the treatment itself.

The vaginal laser treatment is generally well tolerated and patients do extremely well following the MonaLisa Touch® treatment & procedure however some patients may experience some mild irritation and vaginal discharge after the procedure.

The MonaLisa Touch® requires no downtime. The only restriction is to refrain from intercourse 2 days prior and 7 days after and avoid any rigorous exercise for 4 days following vaginal atrophy treatment.

Many patients report a noticeable difference in symptom relief after just one treatment, however, an initial series of three treatments is recommended, spaced at four to six week intervals, to achieve optimal and longer-lasting relief. In order to maintain results, a yearly treatment is highly recommended.